Morio Takahashi
Overview
Explore the profile of Morio Takahashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suda T, Takahashi M, Katayama Y, Soga K, Kobori I, Kusano Y, et al.
World J Clin Cases
. 2023 Aug;
11(23):5462-5467.
PMID: 37637693
Background: We have previously demonstrated that the first wave of the coronavirus disease 2019 (COVID-19) pandemic caused exacerbations in ulcerative colitis (UC) patients, probably through psychological and physical stress. However,...
2.
Suda T, Takahashi M, Katayama Y, Tamano M
World J Clin Cases
. 2022 Jan;
9(36):11220-11227.
PMID: 35071552
Background: In 2020, the world faced the unprecedented crisis of coronavirus disease 2019 (COVID-19). Besides the infection and its consequences, COVID-19 also resulted in anxiety and stress resulting from severe...
3.
Katayama Y, Toyoda K, Kusano Y, Suda T, Adachi S, Terauchi I, et al.
Gut
. 2016 May;
66(4):752-753.
PMID: 27196582
No abstract available.
4.
Takahashi M, Katayama Y
J Gastroenterol Hepatol
. 2010 Aug;
25(9):1493-7.
PMID: 20796145
Background And Aim: The attenuated antisecretory activity of H2-receptor antagonists (H2RA) during continuous administration is referred to as the tolerance phenomenon. A previous study indicated that Helicobacter pylori (H. pylori)...
5.
Takahashi M, Katayama Y, Suzuki K, Koizumi K, Nishida K, Kuwayama H
J Clin Gastroenterol
. 2010 Apr;
44(10):720-2.
PMID: 20421809
No abstract available.
6.
Katayama Y, Takahashi M, Kuwayama H
Biochem Biophys Res Commun
. 2009 Aug;
388(3):496-500.
PMID: 19665002
Previous reports have indicated that Helicobacter pylori (H. pylori) causes epigenetic changes of certain genes such as cancer suppression genes, which may be associated with carcinogenesis. However, the mechanism by...
7.
Tajima A, Koizumi K, Suzuki K, Higashi N, Takahashi M, Shimada T, et al.
J Gastroenterol Hepatol
. 2009 Jan;
23 Suppl 2:S237-41.
PMID: 19120905
Peptic ulcer disease (PUD) is one of the main lesions responsible for upper gastrointestinal (GI) bleeding, as well as esophageal varices and Mallory-Weiss tear. Helicobacter pylori and non-steroidal anti-inflammatory drugs...
8.
Sohma R, Takahashi M, Takada H, Takada H, Kuwayama H
J Gastroenterol Hepatol
. 2007 Oct;
22(11):1965-70.
PMID: 17914978
Background And Aim: Recently, we reported on the beneficial clinical effects of eicosapentaenoic acid (EPA) in patients with primary biliary cirrhosis (PBC) who were unresponsive to ursodeoxycholic acid (UDCA). In...
9.
Takahashi M, Katayama Y, Suzuki K, Tajima A, Oka S, Koizumi K, et al.
Nihon Rinsho
. 2007 May;
65(5):852-63.
PMID: 17511224
GERD (gastro esophageal reflux disease) is defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. Endoscopic-positive GERD can be easily diagnosed with...
10.
Gon S, Irie Y, Takahashi M
Jpn J Thorac Cardiovasc Surg
. 2006 Aug;
54(7):278-84.
PMID: 16898640
Objectives: Upper gastrointestinal bleeding, particularly from a stress-induced duodenal ulcer, is an extremely important perioperative complication in cardiovascular surgery. Methods: In the present study, 33 patients undergoing elective open heart...